THE Therapeutic Goods
Administration has designated
Lucassin (terlipressin acetate) and
ATG-Fresenius (immunoglobulin -
antithymocyte) as orphan drugs.
Lucassin is sponsored by Ikaria
Australia and is indicated for the
treatment of patients with
hepatorenal syndrome type 1 and
for the treatment of oesophageal
variceal haemmorhage.
ATG-Fresenius’ sponsor is Dutec
Diagnostics Pty Ltd, and it’s
indicated for the prevention of graft
versus host disease in allogeneic
haematopoeitic stem cell
transplantation.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Jul 10
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.